EXCEL-Punjabi: A Culturally Tailored Exercise Oncology Pilot Feasibility Intervention (EXCEL-Punjabi)
2026年6月8日 更新者：University of Calgary
EXCEL-Punjabi: Tailored Exercise Oncology for the South Asian Population
The goal of this pilot feasibility study is to explore the feasibility and exploratory effects of a culturally-tailored exercise oncology intervention in Punjabi-speaking individuals of South Asian heritage and their support persons. The main questions it aims to answer are:
- What is the feasibility and acceptability of the EXCEL-Punjabi intervention?
- What are the exploratory effects (i.e., psychosocial and physical changes) before and after program delivery?
Participants will take part in a 12-week exercise oncology intervention consisting of twice weekly hour long multimodal circuit-based exercise sessions. They will also complete questionnaires and functional fitness assessments pre- and post- intervention.
調査の概要
研究の種類
介入
入学 (実際)
12
段階
- 適用できない
連絡先と場所
このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。
研究場所
-
-
Alberta
-
Calgary、Alberta、カナダ、T2N 1N4
- Genesis Centre Calgary
-
-
参加基準
研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。
適格基準
就学可能な年齢
- 大人
- 高齢者
健康ボランティアの受け入れ
はい
説明
Inclusion Criteria:
- Punjabi-speaking
- Self-identified as being of South Asian heritage
- over the age of 18
- pre-, post-, or currently receiving cancer treatment or a support person of an individual living with and beyond cancer
- cleared to participate in, at minimum, mild intensity exercise by a Clinical Exercise Physiologist
- Able to provide informed consent
Exclusion Criteria:
- under the age of 18
- not cleared to exercise by a Clinical Exercise Physiologist
研究計画
このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：支持療法
- 割り当て：なし
- 介入モデル：単一グループの割り当て
- マスキング：なし（オープンラベル）
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的：EXCEL-Punjabi
Culturally Tailored Exercise Oncology Intervention
|
Culturally Tailored Exercise Oncology Intervention
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Measurement Completion
時間枠：Baseline to the end of the intervention (12 weeks)
|
Participants who completed all pre- and post- questionnaires and functional assessments
|
Baseline to the end of the intervention (12 weeks)
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Referrals
時間枠：Baseline to end of intervention (12 weeks)
|
Number of participants referred to intervention
|
Baseline to end of intervention (12 weeks)
|
|
Consented
時間枠：Recruitment to end of intervention (12 weeks)
|
Number of participants who consented to participate in the intervention
|
Recruitment to end of intervention (12 weeks)
|
|
Enrolled
時間枠：Baseline (week 0)
|
Number of participants who enrolled (i.e. completed baseline assessments)
|
Baseline (week 0)
|
|
Attendance
時間枠：Baseline to end of intervention (12 weeks)
|
Intervention Attendance
|
Baseline to end of intervention (12 weeks)
|
|
Adverse Events
時間枠：Baseline to end of intervention (12 weeks)
|
Using the standardized Common Terminology Criteria for Adverse Events Version 6.0
|
Baseline to end of intervention (12 weeks)
|
|
Time Required to Deliver and Implement Intervention
時間枠：From recruitment to end of intervention (12 weeks)
|
Time requirement to deliver intervention
|
From recruitment to end of intervention (12 weeks)
|
|
Physical Activity Level
時間枠：Baseline to end of intervention (12 weeks)
|
The Godin Leisure Time Exercise Questionnaire is used to determine subjective levels of physical activity in each participant.
Participants report how many times per week they partake in mild, moderate, and/or strenuous exercise.
Higher scores indicate a more physically active lifestyle.
|
Baseline to end of intervention (12 weeks)
|
|
Cancer related symptoms
時間枠：Baseline to end of intervention (12 weeks)
|
Change in Edmonton Symptom Assessment Scale - revised: cancer.
Scale is from 0-10, where 0 means the symptom is absent and 10 means the worst possible severity of the symptom is being experienced.
|
Baseline to end of intervention (12 weeks)
|
|
Health Related Quality of Life
時間枠：Baseline to end of intervention (12 weeks)
|
Change in EuroQual - 5Dimensions (EQ-5D) tool - first section is a questionnaire; last section uses a scale from 0-100, where 0 means the worst health imaginable and 100 means the best health imaginable.
|
Baseline to end of intervention (12 weeks)
|
|
Fatigue
時間枠：Baseline to end of intervention (12 weeks)
|
Change in Functional Assessment of Chronic Illness Therapy - Fatigue subscale - scale is from 0-4, where 0 means "not at all" and 4 means "very much".
|
Baseline to end of intervention (12 weeks)
|
|
Cancer Related Quality of Life
時間枠：Baseline to end of intervention (12 weeks)
|
A 5-point Likert scale (0 = not at all, to 4 = very much) to track wellbeing over the course of the cancer journey.
|
Baseline to end of intervention (12 weeks)
|
|
Exercise Barriers Self-Efficacy
時間枠：Baseline to end of intervention (12 weeks)
|
Exercise barriers and facilitators questionnaire
|
Baseline to end of intervention (12 weeks)
|
|
Cognition
時間枠：Baseline to end of intervention (12 weeks)
|
Cancer related cognition using the Functional Assessment of Cancer Therapy - Cognition questionnaire.
A 37-item, self-report questionnaire used to evaluate how cancer patients perceive their own cognitive abilities
|
Baseline to end of intervention (12 weeks)
|
|
Aerobic Capacity
時間枠：Baseline to end of intervention (12 weeks)
|
In-person participants will be assessed on change in 6-minute walk test (m) results
|
Baseline to end of intervention (12 weeks)
|
|
Aerobic Capacity
時間枠：Baseline to end of intervention (12 weeks)
|
Online participants will be assessed with change in the 2-minute step test (number of steps) results.
|
Baseline to end of intervention (12 weeks)
|
|
Lower body strength
時間枠：Baseline to end of intervention (12 weeks)
|
Change in sit-to-stand (number of repetitions in 30 seconds)
|
Baseline to end of intervention (12 weeks)
|
|
Upper extremity flexibility
時間枠：Baseline to end of intervention (12 weeks)
|
Change in active shoulder flexion range of motion (degrees)
|
Baseline to end of intervention (12 weeks)
|
|
Balance
時間枠：Baseline to end of intervention (12 weeks)
|
Change in one legged stance test (seconds)
|
Baseline to end of intervention (12 weeks)
|
協力者と研究者
ここでは、この調査に関係する人々や組織を見つけることができます。
出版物と役立つリンク
研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。
一般刊行物
- Cheifetz O, Park Dorsay J, Hladysh G, Macdermid J, Serediuk F, Woodhouse LJ. CanWell: meeting the psychosocial and exercise needs of cancer survivors by translating evidence into practice. Psychooncology. 2014 Feb;23(2):204-15. doi: 10.1002/pon.3389. Epub 2013 Sep 6.
- Campbell KL, Winters-Stone KM, Wiskemann J, May AM, Schwartz AL, Courneya KS, Zucker DS, Matthews CE, Ligibel JA, Gerber LH, Morris GS, Patel AV, Hue TF, Perna FM, Schmitz KH. Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable. Med Sci Sports Exerc. 2019 Nov;51(11):2375-2390. doi: 10.1249/MSS.0000000000002116.
- Cormie P, Zopf EM, Zhang X, Schmitz KH. The Impact of Exercise on Cancer Mortality, Recurrence, and Treatment-Related Adverse Effects. Epidemiol Rev. 2017 Jan 1;39(1):71-92. doi: 10.1093/epirev/mxx007.
- McNeely ML, Sellar C, Williamson T, Shea-Budgell M, Joy AA, Lau HY, Easaw JC, Murtha AD, Vallance J, Courneya K, Mackey JR, Parliament M, Culos-Reed N. Community-based exercise for health promotion and secondary cancer prevention in Canada: protocol for a hybrid effectiveness-implementation study. BMJ Open. 2019 Sep 13;9(9):e029975. doi: 10.1136/bmjopen-2019-029975.
- King-Shier K, Lau A, Fung S, LeBlanc P, Johal S. Ethnocultural influences in how people prefer to obtain and receive health information. J Clin Nurs. 2018 Apr;27(7-8):e1519-e1528. doi: 10.1111/jocn.14281. Epub 2018 Mar 30.
- Loeb S, Borno HT, Gomez S, Ravenell J, Myrie A, Sanchez Nolasco T, Byrne N, Cole R, Black K, Stair S, Macaluso JN, Walter D, Siu K, Samuels C, Kazemi A, Crocker R, Sherman R, Wilson G, Griffith DM, Langford AT. Representation in Online Prostate Cancer Content Lacks Racial and Ethnic Diversity: Implications for Black and Latinx Men. J Urol. 2022 Mar;207(3):559-564. doi: 10.1097/JU.0000000000002257. Epub 2022 Feb 4.
- Bhandari D, Ozaki A, Kobashi Y, Higuchi A, Shakya P, Tanimoto T. Cancer information seeking and scanning behavior among Nepalese migrants in Japan and its association with preventive behavior. PLoS One. 2020 Jun 29;15(6):e0235275. doi: 10.1371/journal.pone.0235275. eCollection 2020.
- Caperchione CM, Chau S, Walker GJ, Mummery WK, Jennings C. Gender-Associated Perceptions of Barriers and Motivators to Physical Activity Participation in South Asian Punjabis Living in Western Canada. J Phys Act Health. 2015 May;12(5):686-93. doi: 10.1123/jpah.2013-0208. Epub 2013 Aug 7.
- Wagoner CW, Dreger J, Keats MR, Santa Mina D, McNeely ML, Cuthbert C, Capozzi LC, Francis GJ, Trinh L, Sibley D, Langley J, Chiekwe J, Ester M, Foucaut AM, Culos-Reed SN. First-Year Implementation of the EXercise for Cancer to Enhance Living Well (EXCEL) Study: Building Networks to Support Rural and Remote Community Access to Exercise Oncology Resources. Int J Environ Res Public Health. 2023 Jan 20;20(3):1930. doi: 10.3390/ijerph20031930.
- Heston AH, Schwartz AL, Justice-Gardiner H, Hohman KH. Addressing physical activity needs of survivors by developing a community-based exercise program: LIVESTRONG(R) at the YMCA. Clin J Oncol Nurs. 2015 Apr;19(2):213-7. doi: 10.1188/15.CJON.213-217.
- Haas BK, Kimmel G, Hermanns M, Deal B. Community-based FitSTEPS for life exercise program for persons with cancer: 5-year evaluation. J Oncol Pract. 2012 Nov;8(6):320-4, 2 p following 324. doi: 10.1200/JOP.2012.000555. Epub 2012 Jul 24.
- Leach HJ, Danyluk JM, Nishimura KC, Culos-Reed SN. Evaluation of a Community-Based Exercise Program for Breast Cancer Patients Undergoing Treatment. Cancer Nurs. 2015 Nov-Dec;38(6):417-25. doi: 10.1097/NCC.0000000000000217.
- Leach HJ, Danyluk JM, Culos-Reed SN. Design and implementation of a community-based exercise program for breast cancer patients. Curr Oncol. 2014 Oct;21(5):267-71. doi: 10.3747/co.21.2079.
- Culos-Reed N, Wagoner CW, Dreger J, McNeely ML, Keats M, Santa Mina D, Cuthbert C, Capozzi LC, Francis GJ, Chen G, Ester M, McLaughlin E, Eisele M, Sibley D, Langley J, Chiekwe J, Christensen T; EXCEL Project Team. Implementing an exercise oncology model to reach rural and remote individuals living with and beyond cancer: a hybrid effectiveness-implementation protocol for project EXCEL (EXercise for Cancer to Enhance Living Well). BMJ Open. 2022 Dec 29;12(12):e063953. doi: 10.1136/bmjopen-2022-063953.
- Hardcastle SJ, Cohen PA. Effective Physical Activity Promotion to Survivors of Cancer Is Likely to Be Home Based and to Require Oncologist Participation. J Clin Oncol. 2017 Nov 10;35(32):3635-3637. doi: 10.1200/JCO.2017.74.6032. Epub 2017 Sep 15. No abstract available.
- Bansal M, Rana B, Ghotra H, King-Shier K, Bridel W, Culos-Reed SN. Exploring physical activity experiences, barriers, and facilitators among individuals of South Asian heritage living with and beyond cancer. Ethn Health. 2023 Nov;28(8):1085-1102. doi: 10.1080/13557858.2023.2224951. Epub 2023 Jun 14.
研究記録日
これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。
主要日程の研究
研究開始 (実際)
2025年7月1日
一次修了 (実際)
2025年12月12日
研究の完了 (実際)
2025年12月12日
試験登録日
最初に提出
2026年5月11日
QC基準を満たした最初の提出物
2026年6月8日
最初の投稿 (実際)
2026年6月11日
学習記録の更新
投稿された最後の更新 (実際)
2026年6月11日
QC基準を満たした最後の更新が送信されました
2026年6月8日
最終確認日
2026年5月1日
詳しくは
本研究に関する用語
その他の研究ID番号
- HREBA.CC-25-0150
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
いいえ
IPD プランの説明
Aggregate and participant-level results are reported within publications, but there is no formal plan for external IPD sharing.
With a small sample size from a specific cultural group, there may be risk of re-identification.
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
いいえ
米国FDA規制機器製品の研究
いいえ
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。
癌の臨床試験
-
Novartis Pharmaceuticals終了しましたメラノーマ | 高度なEGFR変異体非小さな細胞肺cancer（NSCLC） | KRAS G12変異NSCLC | 食道扁平上皮がん（SCC） | ヘッド/ネックSCC | 進行した胃腸間質腫瘍（GIST） | 進行したNRAS/BRAFT WT皮膚黒色腫アメリカ, 台湾, オランダ, カナダ, スペイン, シンガポール, イタリア, 日本, 韓国
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI); Highlight Therapeutics積極的、募集していない平滑筋肉腫 | 悪性末梢神経鞘腫瘍 | 滑膜肉腫 | 未分化多形肉腫 | 骨の未分化高悪性度多形肉腫 | 粘液線維肉腫 | II期の体幹および四肢の軟部肉腫 AJCC v8 | III期の体幹および四肢の軟部肉腫 AJCC v8 | IIIA 期の体幹および四肢の軟部肉腫 AJCC v8 | IIIB 期の体幹および四肢の軟部肉腫 AJCC v8 | 切除可能な軟部肉腫 | 多形性横紋筋肉腫 | 切除可能な脱分化型脂肪肉腫 | 切除可能な未分化多形肉腫 | 軟部組織線維肉腫 | 紡錘細胞肉腫 | ステージ I 後腹膜肉腫 AJCC (American Joint Committee on Cancer) v8 | 体幹および四肢の I 期軟部肉腫 AJCC v8 | ステージ... およびその他の条件アメリカ
EXCEL-Punjabiの臨床試験
-
Second Affiliated Hospital, School of Medicine,...完了
-
JW Medical Systems Ltd完了心筋虚血 | 心臓疾患 | 心血管疾患 | 血管疾患 | 冠動脈疾患 | 冠動脈疾患 | 動脈硬化 | 動脈閉塞性疾患中国
-
The Cleveland ClinicCryothermic Systems, Inc.終了しました
-
Cutera Inc.完了
-
University of PortsmouthUniversity of Sheffield; University of Bath; Portsmouth Hospitals NHS Trust; The Dunhill Medical... と他の協力者完了